The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
Open accessAbstract
BACKGROUND: Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated. METHODS: We enrolled 17,622 women aged 16-26 years. All underwent cervicovaginal sampling and Pap testing at regular intervals for up to 4 years. HPV genotyping was performed for biopsy samples, and histological diagnoses were determined by a pathology panel. Analyses were conducted among subjects who were negative for 14 HPV types on day 1. Prespecified analyses included infection of 6 months' duration and CIN1-3/AIS due to the 2 and 5 most common HPV types in cervical cancer after HPV types 16 and 18, as well as all tested nonvaccine types. RESULTS: Vaccination reduced the incidence of HPV-31/45 infection by 40.3% (95% confidence interval [CI], 13.9% to 59.0%) and of CIN1-3/AIS by 43.6% (95% CI, 12.9% to 64.1%), respectively. The reduction in HPV-31/33/45/52/58 infection and CIN1-3/AIS was 25.0% (95% CI, 5.0% to 40.9%) and 29.2% (95% CI, 8.3% to 45.5%), respectively. Efficacy for CIN2-3/AIS associated with the 10 nonvaccine HPV types was 32.5% (95% CI, 6.0% to 51.9%). Reductions were most notable for HPV-31. CONCLUSIONS: HPV-6/11/16/18 vaccine reduced the risk of CIN2-3/AIS associated with nonvaccine types responsible for approximately 20% of cervical cancers. The clinical benefit of cross-protection is not expected to be fully additive to the efficacy already observed against HPV-6/11/16/18-related disease, because women may have >1 CIN lesion, each associated with a different HPV type. TRIAL REGISTRATION: ClinicalTrials.gov identifiers: NCT00092521 , NCT00092534 , and NCT00092482.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Self-citationClassification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Self-citationSmith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22527 · Cited by 1,686
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Self-citationChapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Self-citationClifford, G. M., Smith, J. S., Aguado, T., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601024 · Cited by 684
Singleton, R. J., Hennessy, T. W., Bulkow, L. R., Hammitt, L. L., Zulz, T., Hurlburt, D. A., Butler, J. C., Rudolph, K., & Parkinson, A. (2007) · JAMA · doi:10.1001/jama.297.16.1784 · Cited by 615
Ault, K. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60852-6 · Cited by 590
Self-citationBreitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., & Lowy, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3959-3963.1995 · Cited by 589
Joura, E. A., Leodolter, S., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Garland, S. M., Harper, D. M., Tang, G. W., Ferris, D. G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60777-6 · Cited by 581
Self-citationClifford, G. M., Rana, R. K., Franceschi, S., Smith, J. S., Gough, G., & Pimenta, J. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0812 · Cited by 533
Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., Harper, D. M., Kinney, W., Moscicki, A.-B., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.7 · Cited by 521
Self-citationChapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia
Schiffman, M., & Kjaer, S. K. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003476 · Cited by 513
Self-citationCumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis
Kim, H. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1210 · Cited by 507
Olsson, S.-E., Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Malm, C., Iversen, O.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.049 · Cited by 454
Self-citationMao, C., Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Wiley, D. J., Alvarez, F. B., Bautista, O. M., Jansen, K. U., & Barr, E. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000192397.41191.fb · Cited by 451
Self-citationPlummer, M., Schiffman, M., Castle, P. E., Maucort‐Boulch, D., Wheeler, C. M., & ALTS (Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study) Group (2007) · The Journal of Infectious Diseases · doi:10.1086/516784 · Cited by 426
Self-citationAnalysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy
Chan, S. Y., Delius, H., Halpern, A. L., & Bernard, H. U. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3074-3083.1995 · Cited by 411
Prevention of cervical cancer through papillomavirus vaccination
Frazer, I. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1260 · Cited by 402
External Genital Warts: Diagnosis, Treatment, and Prevention
Wiley, D. J., Douglas, J., Beutner, K., Cox, T., Fife, K., Moscicki, A., & Fukumoto, L. (2002) · Clinical Infectious Diseases · doi:10.1086/342109 · Cited by 354
Lipsitch, M. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990304 · Cited by 286
Determinants of Genital Human Papillomavirus Detection in a US Population
Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M., Apple, R. J., & Wheeler, C. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/320696 · Cited by 252
Self-citationOng, C. K., Chan, S. Y., Campo, M. S., Fujinaga, K., Mavromara-Nazos, P., Labropoulou, V, Pfister, H., Tay, S. K., ter Meulen, J., & Villa, L. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6424-6431.1993 · Cited by 251
Self-citationThe viral etiology of cervical cancer
Bosch, F. X., & Muñoz, N. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00187-9 · Cited by 218
Self-citationSrodon, M., Stoler, M. H., Baber, G. B., & Kurman, R. J. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213291.96401.48 · Cited by 213
Self-citationThe FUTURE II Study Group (2007) · The Journal of Infectious Diseases · doi:10.1086/522864 · Cited by 182
Méndez, F., Muñoz, N., Posso, H., Molano, M., Moreno, V., van den Brule, A. J. C., Ronderos, M., Meijer, C., Muñoz, Á., & Instituto Nacional de Cancerología Human Papillomavirus Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/444391 · Cited by 160
Self-citationHuman Papillomavirus Genotypes and the Cumulative 2‐Year Risk of Cervical Precancer
Wheeler, C. M., Hunt, W. C., SCHIFFMAN, M. H., Castle, P. E., & Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2006) · The Journal of Infectious Diseases · doi:10.1086/507909 · Cited by 145
Self-citationHuman papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions
Smith, J. F., Brownlow, M., Brown, M. J., Kowalski, R., Esser, M. T., Ruiz, W., Barr, E., Brown, D. R., & Bryan, J. T. (2007) · Human Vaccines · doi:10.4161/hv.3.4.4058 · Cited by 137
Self-citationDeveloping an HPV vaccine to prevent cervical cancer and genital warts
Bryan, J. T. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.013 · Cited by 123
Self-citationIntratype variation in 12 human papillomavirus types: a worldwide perspective
Stewart, A. C., Eriksson, A. M., Manos, M. M., Muñoz, N., Bosch, F. X., Peto, J., & Wheeler, C. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3127-3136.1996 · Cited by 122
Self-citationChristensen, N. D., Reed, C. A., Cladel, N. M., Hall, K., & Leiserowitz, G. S. (1996) · Virology · doi:10.1006/viro.1996.0554 · Cited by 117
Actual and Actuarial Probabilities of Competing Risks: Apples and Lemons
Grunkemeier, G. L., Jin, R., Eijkemans, M. J. C., & Takkenberg, J. J. M. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.11.044 · Cited by 84
Silins, I., Wang, Z., Lundqvist, E. Å., Frankendal, B., Vikmanis, U., Sapp, M. J., Schiller, J. T., & Dillner, J. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-11-2931 · Cited by 70
Self-citationPlummer, M., SCHIFFMAN, M. H., Castle, P. E., Maucort‐Boulch, D., & Wheeler, C. M. (2008) · Journal of Lower Genital Tract Disease · doi:10.1097/01.lgt.0000305247.00437.26 · Cited by 65
Self-citationThe Bethesda System 2001: an update of new terminology for gynecologic cytology
Henry, M. R. (2003) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(03)00053-2 · Cited by 61
Garland, S. M., Steben, M., Hernández‐Ávila, M., Koutsky, L. A., Wheeler, C. M., Pérez, G., Harper, D. M., Leodolter, S., Tang, G., Ferris, D. G., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00478-06 · Cited by 47
Self-citationHuman papillomavirus infection and cervical cancer
Sasagawa, T. (2003) · Biomedical Reviews · doi:10.14748/bmr.v14.110 · Cited by 41
Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines
Hildesheim, A., Markowitz, L. E., Hernández‐Ávila, M., & Franceschi, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.102 · Cited by 16
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Self-citationA 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationEfficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0909537 · Cited by 1,146
Self-citation
Metadata
- Authors
- Brown, D. R., Kjaer, S. K., Sigurdsson, K., Iversen, O., Hernandez‐Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Tay, E. H., Garcia, P., Ault, K. A., Garland, S. M., Leodolter, S., Olsson, S., Tang, G. W. K., Ferris, D. G., Paavonen, J., Steben, M., Bosch, F. X., Dillner, J., Joura, E. A., Kurman, R. J., Majewski, S., Muñoz, N., Myers, E. R., Villa, L. L., Taddeo, F. J., Roberts, C., Tadesse, A., Bryan, J., Lupinacci, L. C., Giacoletti, K. E. D., Sings, H. L., James, M., Hesley, T. M., & Barr, E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04
- Volume
- 199
- Issue
- 7
- Pages
- 926-935
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2123962939
- Cited by
- 627
- References
- 44
- FWCI
- 50.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.